Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia.
J Microbiol Immunol Infect
; 54(1): 109-112, 2021 Feb.
Article
in English
| MEDLINE | ID: covidwho-813695
ABSTRACT
No specific therapy is available for COVID-19. We report the effectiveness and adverse effects of triple therapy with hydroxychloroquine, azithromycin, and ciclesonide in patients with COVID-19 pneumonia. The clinical condition of the patients improved within 5 days in response to the therapy.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Pregnenediones
/
Azithromycin
/
COVID-19 Drug Treatment
/
Hydroxychloroquine
Type of study:
Observational study
/
Prognostic study
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Asia
Language:
English
Journal:
J Microbiol Immunol Infect
Journal subject:
Allergy and Immunology
/
Microbiology
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS